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Background—One lung ventilation (OLV) results in inflammatory and mechanical injury,
leading to intraoperative and postoperative complications in children. No interventions have been
studied in children to minimize such injury.
Objective—We hypothesized that a single 2-mg/kg dose of methylprednisolone given 45–60
minutes prior to lung collapse will minimize injury from OLV and improve physiological stability.
Methods—Twenty-eight children scheduled to undergo OLV were randomly assigned to receive
2 mg/kg methylprednisolone (MP) or normal saline (placebo group) prior to OLV. Anesthetic
management was standardized, and data were collected for physiological stability (bronchospasm,
respiratory resistance, and compliance). Plasma was assayed for inflammatory markers related to
lung injury at timed intervals related to administration of methylprednisolone.

Author Manuscript

Results—Three children in the placebo group experienced clinically significant intraoperative
and postoperative respiratory complications. Respiratory resistance was lower (P = 0.04) in the
methylprednisolone group. Pro-inflammatory cytokine IL-6 was lower (P = 0.01) and antiinflammatory cytokine IL-10 was higher (P = 0.001) in the methylprednisolone group. Tryptase,
measured before and after OLV, was lower (P = 0.03) in the methylprednisolone group while
increased levels of tryptase were seen in placebo group after OLV (did not achieve significance).
There were no side effects observed that could be attributed to methylprednisolone in this study.
Conclusions—Methylprednisolone at 2 mg/kg given as a single dose prior to OLV provides
physiological stability to children undergoing OLV. In addition, methylprednisolone results in
lower pro-inflammatory markers and higher anti-inflammatory markers in the children's plasma.
Keywords
Pediatrics; one lung ventilation; methylprednisolone; cytokines; tryptases; oxidative stress

Author Manuscript

Introduction
Video-assisted thoracoscopic surgery has made one lung ventilation (OLV) necessary in
children.1 Injury from OLV includes endothelial dysfunction, alveolar edema, disruption of
type-1 pneumocytes, and infiltration of polymorphonuclear cells.2-4 In this study, we took
advantage of the fact that OLV is a pre-planned iatrogenic injury, allowing an opportunity to
institute an intervention to minimize known associated injuries.

Author Manuscript

The intervention proposed here, a single dose (2 mg/kg) of methylprednisolone (MP) given
prior to OLV, was studied in our piglet model of OLV.5 It demonstrated reduced
inflammatory markers both in plasma and the lung tissue and was shown to further decrease
neutrophil infiltrates in the alveoli.5 Our primary hypothesis for this clinical study was that
MP given in a single dose of 2 mg/kg prior to OLV would result in improved physiological
stability by decreasing the incidence of bronchospasm and failure of OLV in children. Our
second hypothesis was that MP would decrease the pro-inflammatory markers tumor
necrosis factor (TNF)-α and interleukin (IL)-6 while increasing the anti-inflammatory
marker IL-10 during and after OLV in children.6,7 We also examined the influence of MP
on serum tryptase, which is a known marker of lung injury, resulting from ischemia-
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reperfusion8 as was evident from our own prior clinical experience with OLV-related
complications.*

Methods
Study Design
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The study was a randomized, double-blinded, placebo-controlled clinical trial of parallel
design. After we obtained IRB approval, a study coordinator obtained parental consent and
child's consent/assent to enroll children aged 3–18 years. The coordinator collected data and
performed all assays of inflammatory markers and was blinded to the grouping of the
subjects. Only the anesthesiologist responsible for the child was made aware of the
grouping. Once enrolled, the children were randomized using a random number table and a
simple random allocation to either the placebo group, who received 2 ml of normal saline
intravenously, or to the MP group, who received a single dose of 2 mg/kg MP intravenously
(maximum dose 80 mg) 45–60 minutes prior to OLV. The placebo and MP were prepared
by a pharmacist (in a 2-ml syringe labeled study drug) who randomized patients and
maintained the record for group assignment. This was the only individual with access to that
database. Neither the investigator nor the child/parents knew the group assignment.
Exclusion criteria were presence of malignant lesions, acute infections such as sepsis or
pneumonia, hepatic or renal failure, autoimmune diseases, and use of oral steroids within
three months prior to surgery. The only change in eligibility criteria during the course of
study was the enrollment of Spanish speaking patients after the approval of the consent form
in Spanish.
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Anesthetic Background
The anesthetic was standardized to consist of premedication using midazolam followed by
induction of general anesthesia using sevoflurane in 100% inhaled oxygen prior to securing
an intravenous line. Anesthesia was maintained using infusions of propofol at 50–100 mcg ·
kg−1 · min−1, fentanyl at 3 mcg · kg−1 · hr−1, and sevoflurane 1–2% in 50% oxygen and air.
The baseline measurements were done following tracheal intubation and arterial line
placement, after which either the placebo or the study drug was given intravenously.
OLV Procedure
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Using a flexible pediatric bronchoscope, an Arndt endobronchial blocker (Cook Critical
Care, Bloomington, IN, USA) was placed under direct vision to either the right or left
mainstem bronchus via the three-way adaptor that allows uninterrupted ventilation. After the
patients were positioned in a lateral position, the balloon was inflated under direct vision to
block the operative-side lung. Tidal volume (TV), positive end expiratory pressure (PEEP),
and inspired oxygen (FiO2) settings used for the study were as follows:
•

Bilateral ventilation (BLV): TV, 8–10 ml/kg + PEEP, 5; FiO2, 50%

*Dixit D, Theroux MC, Shah S, Costarino A. Cardiovascular collapse in a patient undergoing single lung ventilation. ASA case
presentation. SPA/ASA joint meeting, Oct 12, 2007, San Francisco, CA.
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•

OLV: TV, 5 ml/kg + PEEP, 5; FiO2, 100%
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The respiratory rate was adjusted to keep end-tidal CO2 (EtCO2) levels between 35–45 torr
during (BLV) but was permitted to be in the range of 45–55 torr during OLV.
Outcome Measures Examined
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Incidence of obstructive airway pattern was defined as: 1) a rise in EtCO2 up to 65
mmHg or greater with an up-sloping of the EtCO2 wave form, with or without an associated
decrease in oxygen saturation; 2) a 50% or greater rise in peak airway pressure compared to
baseline (with no obvious occlusion of the endotracheal tube). Auscultation of lungs was not
used as a criterion because of difficulty in accessing the chest during the procedure. Inability
to tolerate OLV for any reason was also recorded. Respiratory mechanical parameters
(dynamic compliance and resistance) were measured at baseline (before OLV) and 20 min
after expansion of collapsed lung (end-OLV) using a commercially available, stand-alone
pediatric monitoring system (CO2SMO Plus; Novametrix, Wallingford, CT, USA). The
reported measurements were based on the average of at least 10 consecutive breaths. Peak
inflation pressure, mean airway pressure (MAP), and blood gas parameters and glucose were
measured at the same time points.
Measurement of Pro-Inflammatory Cytokines and Tryptase in the Plasma
The plasma cytokines were collected in blue-top tubes at time points referenced to the time
when the study drug was administered as follows:

○

Baseline

Prior to study drug administration

Author Manuscript

○

OLV20

20 min after collapse of lung

○

OLV 6hrs

6 hours after study drug administration

○

OLV 18hrs

18 hours after study drug administration

After centrifugation, the levels of TNF-α, IL-6, and IL-10 in plasma samples collected were
measured in duplicate with quantitative ELISA using human-specific Quantikine ELISA kits
(R&D Systems, Minneapolis, MN, USA). The test sensitivities for respective immunoassays
were as follows: TNF-α, 1.6 pg/mL; IL-6, 0.70 pg/mL; and IL-10, 3.9 pg/mL. Inter- and
intra-assay coefficients of variance were < 10%. Blood was drawn for tryptase levels before
OLV and 20 minutes after onset of OLV and sent to the clinical lab (Quest Diagnostics,
Exton, PA) for tryptase assay.

Author Manuscript

Power and Sample Size Calculation
Sample size was calculated based on the most known and frequently studied proinflammatory cytokine, IL-6,9 and results of our pre-clinical study.5 To observe a difference
in levels of IL-6 between the groups by 80%, assuming a standard deviation of 60%, risk of
type-1 error of 5%, to achieve a power of 80%, nine patients per group was estimated.
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Interval data (age, weight, duration of OLV, resistance, and weight-based compliance) were
analyzed using Student t test; chi-squared test was used to analyze male-to-female ratio and
laterality of the lung collapsed. Tryptase measured at baseline and repeated at 20 min after
collapse of lung was analyzed using paired sample t test. Cytokine measurements were
analyzed after Log10 transformation (to reduce the volatility and linearize the data)9 using
repeated measures ANOVA to identify group differences as well as group · time
interactions. The duration of OLV was used as covariate to determine its influence on the
cytokine levels. Where significant difference occurred, the effect size was reported using
Cohen's d or partial eta-squared as appropriate.10 All statistical analysis was done using
SPSS 22 (IBM, Armonk, NY, USA). Probability values < 0.05 were considered significant.
Data and Safety Monitoring Plan
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A Data and Safety Monitoring Board was established with the help of our IRB, and
quarterly reports were submitted and approved by the board during the two-year study
period.

Results

Author Manuscript

At the end of the two-year study period, 28 children had been enrolled in the study (placebo
= 15; MP = 13). One child in each group had bilateral thoracoscopic procedures for
recurrent blebs and was excluded from the results. The mean age and weight, ratio of male
to female, and laterality of the lung (right/left) were not significantly different between the
two groups (Table 1). Groups were similar for their core temperature, heart rate, mean
arterial blood pressure, ventilatory rate, and tidal volume used (Table 2). There was no
difference in the partial pressure of carbon dioxide or the ratio of partial pressure of oxygen
(PaO2) to fractional concentration of oxygen (FiO2) (PF ratio) measured at any time points
(Table 2). Glucose levels were also similar in both groups (Table 2). Surgical procedures are
listed in Table 1.
Physiological Stability of the Subjects

Author Manuscript

No children in the MP group experienced bronchospasm, and all completed their course of
OLV without complications. Two children in the placebo group had obstructive airway
events during OLV with up-sloping of the EtCO2 waveform; these events were presumed to
be due to bronchospasm. One of these two children had associated inadequate oxygenation,
which did not improve with ketamine and epinephrine for bronchodilatation or with lung
recruitment maneuvers, and surgery was completed via open thoracotomy. The other child
in the placebo group who experienced bronchospasm received albuterol via endotracheal
tube and ketamine intravenously for bronchodilatation and was able to complete the
procedure but sustained respiratory failure and systemic inflammatory response syndrome
(SIRS) postoperatively. A third child in the placebo group required bi-level positive airway
pressure (BiPAP) ventilation postoperatively and also experienced SIRS. A fourth child in
the placebo group had sub-segmental atelectasis in the right middle lobe of the collapsed
lung and developed fever >101°F. Following cultures, he was placed on antibiotics
empirically. He recovered without sequelae. One child in each group had minimal basilar
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atelectasis on postoperative chest radiograph that resolved without specific treatment other
than routine incentive spirometry.
Resistance increased from baseline to end-OLV11 as expected; however, the increase was
ameliorated in the MP (P = 0.04 t test) compared to placebo group (Fig 1A). Weightadjusted compliance was decreased in both groups at end-OLV but was not significantly
different between the groups (Fig 1B).
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Mean duration of OLV was longer in the MP group, but this difference did not have a
significant influence on any of the cytokine levels. Mean plasma level of IL-6 was greater (P
= 0.01) in the placebo group (Fig 2A) with significant differences occurring at 6 hrs (P =
0.03) and 18 hours (P = 0.02) after study drug administration. Mean plasma value of TNF-α
in the MP group showed an amelioration to treatment with MP but did not achieve a
statistically significant difference (P = 0.2) for group · time (Fig 2B). The mean plasma level
of the anti-inflammatory cytokine IL-10 was significantly higher (P = 0.001) in the MP
group with a significant difference (P = 0.001) occurring at 6 hours following study drug
administration (Fig 2C).
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Similarly, mean serum tryptase was significantly lower (P = 0.03) after 20 minutes of OLV
when compared to baseline values in the MP group, showing an attenuation by MP. In
contrast, the placebo group had a higher mean value of tryptase after 20 minutes of OLV
when compared to the baseline values even though the difference did not achieve statistical
significance (Fig 3). Note that the mean tryptase level in the MP group is higher than the
mean tryptase level in the placebo group for both baseline and OLV20 values. No significant
differences were seen when the mean values were analyzed by t test (Baseline: 1.7 ± 0.9 vs
2.7 ± 1.5 [P = 0 .10]; OLV20: 1.8 ± 1.3 vs 2.2 ± 1.3 [P = 0.48]), indicative of a random
occurrence.

Discussion

Author Manuscript

In this study, we have systematically examined the benefits of a single dose of MP, a wellknown anti-inflammatory agent, given prior to OLV to minimize resultant inflammatory
injury and improve respiratory stability. We employed protective ventilation for all patients
(as defined by the use of low-stretch ventilation of TV 5 ml/kg and PEEP of 5 cms during
the OLV) for its known beneficial effects.9,12,13 Physiological stability of the patients during
OLV is threatened by bronchospasm due to multiple factors such as edema, secretions, and
reflux bronchoconstriction. OLV simulates an endobronchial intubation, which is the most
common cause of bronchospasm in the intraoperative arena, and the beneficial effect of MP
was evident in the lower resistance seen in the MP group after OLV, which contributed to
the absence of bronchospasm in this group. The anti-inflammatory effects of MP in our
study are further supported by the lower levels of IL-6 and higher levels of IL-10 in the MP
group. Levels of IL-6 have been correlated to mortality in adults in intensive care units14
and in children when admitted with sepsis.15
Tryptase, a protease, is familiar to anesthesiologists as a marker of an immunoglobulin E
(IgE)-mediated reaction and bronchospasm. Tryptase elevation also occurs due to injury
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resulting from a flux of reactive oxygen species (ROS) and resultant mast cell
degranulation.16 Such a flux of ROS and mast cell degranulation may be anticipated during
collapse and re-expansion of a lung, similar to that described during ischemia-reperfusion
injuries17,18 and in hyperoxic environments.17,19 Episodes of hypoxemia that are not
explained by the patient's preoperative conditions may occur during OLV,20 as was
observed in two patients in the placebo group. One mechanistic pathway for such episodes
may be the flux of ROS and related cellular events, as we observed (see footnote), where a
healthy child experienced cardiovascular collapse shortly after re-expansion of the collapsed
lung. Suspecting an IgE-mediated allergic reaction, we had drawn a tryptase level, which
was elevated, and further investigation showed it to be because of a non-IgE-mediated mast
cell degranulation. This case, along with the literature describing reperfusion injury where
mast cells are capable of recruiting leukocytes independent of IgE mediation,16-19 helped us
to understand the complex nature of lung injury during and after OLV. The significant
decrease in tryptase level in the MP group after 20 minutes of OLV is a finding not
described before in the anesthesia literature even though MP is commonly administered
during anaphylactic episodes where mast cell degranulation is a major contributing event.
Our choice of MP as an intervention was based on its well known ability to attenuate both
neutrophil activation and recruitment21 and its ability to treat IgE- and non-IgE-mediated
conditions where both basophils and mast cells degranulate.22 Methylprednisolone also has
been shown at endothelial cell level to reduce inflammatory response23 by suppressing
cytokine (TNF-α) production when given preoperatively in asthmatic patients.
Methylprednisolone may down-regulate cytokine release and reduce neutrophil
sequestration and edema.24
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Procedures that necessitate OLV in children are typically different than in adults.13 Our
understanding of OLV mostly relates to adult studies, where pneumonectomy or
esophagectomies9,25 are often the surgical procedure. Underlying parenchymal diseases
such as emphysema or chronic obstructive pulmonary disease are much less prevalent in
children. Thus, pathophysiological mechanism of OLV and its treatment in adults are not
entirely applicable to children. One lung ventilation procedures are often performed in
children with healthy lungs, and the physiological stability that MP imparts in these patients
may be of significant clinical value to pediatric anesthesiologists.

Author Manuscript

The drawbacks of our study are the lack of homogeneity of surgical procedures our subjects
experienced and the small sample size. We hope to have achieved comparable groups by
randomization of subjects, thus eliminating the selection bias and balancing the two groups
with respect to known and unknown confounding variables. In addition, the small sample
size increases the likelihood of type II error, leading to the inability to detect a significant
difference when the effect size was not large. We believe that our preclinical studies in the
animal model helped mitigate the drawbacks in our clinical study and further strengthen our
finding.5,12,19

Conclusion
Methylprednisolone, given at 2 mg/kg before OLV, decreases the pro-inflammatory marker
IL-6 and increases the anti-inflammatory marker IL-10 in the plasma. Further, MP decreases
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tryptase, a marker of mast cell degranulation known to occur due to ROS during OLV.
Overall, our study results show that a single dose of MP (2 mg/kg) given prior to OLV will
result in greater physiological stability by minimizing bronchospasm or obstructive
respiratory events and enabling completion of OLV.
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What is Already Known about the Subject
•

One lung ventilation in children results in inflammatory injury as evidenced by
increase in pro-inflammatory markers, which may result in intraoperative
complications.

•

In earlier studies using a piglet model of OLV, the authors have demonstrated
that a single intravenous dose of methylprednisolone (2 mg/kg) given
prophylactically could minimize such inflammatory injury and improve
physiological stability of the one lung ventilation procedure.

What this Article Adds
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•

This manuscript describes the translational study following the animal studies
and examines the efficacy of methylprednisolone (2 mg/kg) given
prophylactically in minimizing inflammatory parameters, and thus improving
physiological stability, in children undergoing one lung ventilation.

•

The results show that methylprednisolone decreases pro-inflammatory markers
including tryptase and improves physiological stability of the patients
undergoing one lung ventilation.

Implications for Translation
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•

One lung ventilation results in the iatrogenic injury of various severities. As the
injury can be anticipated, it gives the anesthesiologist a unique opportunity to
institute measures to minimize such injury.

•

Methylprednisolone (2 mg/kg) given prior to one lung ventilation decreases
inflammatory injury and should be considered as a preventative measure prior to
one lung ventilation in children. Other anti-inflammatory agents may have
similar results but need further studies demonstrating their efficacy.

Author Manuscript
Paediatr Anaesth. Author manuscript; available in PMC 2016 June 01.

Theroux et al.

Page 11

Author Manuscript
Fig 1.
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Resistance (1A) and compliance (1B) measured at baseline and at termination of one lung
ventilation (end-OLV is measured 20 minutes after re-expansion of collapsed lung). Mean ±
SD are given. The arrow points to the placebo group measurements at end of OLV where
the significant difference occurred (P = 0.04) as indicated by star. Note that mean resistance
was slightly lower for the methylprednisolone group at baseline (11.2 ± 1.3 for
methylprednisolone vs. 12.9 ± 1.5 for placebo), but it was not significantly different (P =
0.44).
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Fig 2.
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2A: Interleukin (IL)-6 in plasma measured at baseline, 20 min after start of OLV (OLV20),
and 6–8 hrs and 16–18 hours following administration of study drug. Mean ± SD are given.
There was a group by time difference by repeated measures ANOVA (P = 0.01). Significant
differences occurred between the groups at the 6-hr (P = 0.03) and 18-hrs (P = 0.02) time
points as indicated by star (t test). Duration of OLV, which was longer in MP group, used as
a co-variate, did not have a significant influence on the (IL)-6 values (P = 0.65). 2B: Tumor
necrosis factor (TNF)-α in plasma measured at baseline, OLV20, and 6–8 hrs and 16–18
hours following administration of study drug. The two groups were not significantly
different by repeated measures ANOVA (P = 0.2). Duration of OLV, used as a co-variate,
did not have a significant influence on the (TNF)-α values (P = 0.82). 2C: Interleukin
(IL)-10 in plasma measured at baseline, OLV20, and 6–8 hrs and 16–18 hours following
administration of study drug. There was a significant group by time difference analyzed by
repeated measures ANOVA (P = 0.001). Significant difference by t test occurred between
the groups at the 6-hr time point (P = 0.001) as indicated by star. Similar to IL-6 and (TNF)α analysis, duration of OLV, used as a co-variate, did not have a significant influence on the
(IL)-10 values (P = 0.16).

Author Manuscript
Paediatr Anaesth. Author manuscript; available in PMC 2016 June 01.

Theroux et al.

Page 13

Author Manuscript
Author Manuscript

Fig 3.

Tryptase in plasma measured at baseline and 20 min past start of OLV (OLV20). Mean ±
SD are given. Tryptase levels were drawn at similar time points (OLV20) for all subjects
and therefore duration of OLV is not a confounding factor for analysis of tryptase levels.
Compared to baseline, mean tryptase at OLV20 was significantly lower (P = 0.03) by
paired-sample t test in the MP group as indicated by star. Mean tryptase level in the MP
group was higher than the mean tryptase level in the placebo group for both baseline and
OLV20, which, when analyzed by t test, did not show a significant difference (1.7 ± 0.9 vs
2.7 ± 1.5 [P = 0 .10]; OLV20: 1.8 ± 1.3 vs 2.2 ± 1.3 [P = 0.48]). We believe this is a random
occurrence.
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Demographic data for placebo and methylprednisolone groups.
Placebo

Methylprednisolone

P value

Age (years)

11.8 ± 3.8

13.6 ± 3.5

0.2

Weight (kg)

45.2 ± 25

41.8 ± 14

0.6

OLV duration (min)

95 ± 65.6

118 ± 70.4

0.4

9/5

5/7

0.2

Male/female

8/6

7/5

0.6

Anterior spine surgery

5

6

Biopsy mass

7

5

Pulmonary bleb

2

1

*

Right/left

**

0.89

Means and standard deviations are reported. Analytical methods used are t test and chi-square.
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*

Indicates which lung was collapsed.

**

Type of surgery was analyzed by chi-square for the three types, and therefore the P value of 0.89 applies to all three surgical procedures listed.
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101 ± 12.9

72.6 ± 18.2

12.6 ± 3.4

9.9 ± 3.4

468 ± 108

40.6 ± 5.4

120 ± 54.7

Heart rate/min

MAP (mmHg)

Vent rate/min

TV (ml/kg)

PF ratio

PCO2 (mmHg)

Glucose (mg/dl)

115.2 ± 29.8

50 ± 11.8

208 ± 107

5.2 ± 0.6

18.2 ± 5.7

77.7 ± 13.4

85.7 ± 17.6

34.8 ± 0.7

108.6 ± 23.4

43.2 ± 11.2

389 ± 153

8.2 ± 1.8

13.3 ± 3.2

68.7 ± 15.9

85.9 ± 19

35.2 ± 0.8

111.9 ± 42

40.8 ± 7.3

508 ± 70

8.6 ± 3.3

11.6 ± 3.1

73.2 ± 12.3

102.5 ± 24.8

35.6 ± 0.3

115.6 ± 32.6

54.3 ± 5.9

258 ± 81

5.0 ± 1.0

16.3 ± 4.1

77.3 ± 15.7

89 ± 10.2

34.9 ± 0.5

125.7 ± 21.6

44.0 ± 10.0

396 ± 148

8.7 ± 2.0

11.3 ± 4.5

72.3 ± 9.8

88.8 ± 17.7

35.4 ± 0.8

BLV 20min

0.23

0.71

0.4

0.62

0.74

0.41

0.39

0.78

P value

Means and standard deviations are reported. Analytical method used is repeated measures ANOVA. BLV, bilateral lung ventilation; MAP, mean airway pressure; Vent, ventilation; TV, tidal volume; PF
ratio, ratio of partial pressure of oxygen to fractional concentration of oxygen; PCO2, partial pressure of carbon dioxide.

35.5 ± 0.7

Temp 0°C

OLV 20min

Baseline

BLV 20 min

Baseline

OLV 20min

Methylprednisolone

Placebo
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Physiological variables during the course of one lung ventilation (OLV).
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